Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bitter kola (Garcinia kola) seeds contain kolaviron—a biflavonoid complex of kolaflavanone, garcinia biflavonoid 1 and 2—that exerts potent antioxidant, anti-inflammatory, hepatoprotective, and antimicrobial activity through modulation of NF-κB signaling, CYP450 enzyme induction, and free radical scavenging (PMID 33185157; PMID 37359709). A comprehensive pharmacological review confirmed that Garcinia kola bioactives demonstrate antiviral, hypoglycemic, anti-parasitic, and intraocular pressure-lowering effects, with a clinical study showing significant reduction in intraocular pressure following oral consumption (PMID 32275352; PMID 35528115).
Reported Benefits (Provisional)
Origin & History
Bitter Kola (Garcinia kola) is a flowering plant native to the tropical forests of West and Central Africa, thriving in nutrient-rich, well-drained soils. Revered in traditional African herbal medicine, its seeds are prized for their potent medicinal, adaptogenic, and detoxifying properties. This botanical offers significant potential for supporting holistic wellness and resilience.
Research Narrative (Provisional)
A critical review by Tauchen (2023) in Phytochemistry Reviews comprehensively catalogued over 60 bioactive compounds from Garcinia kola, documenting antimicrobial, antidiabetic, hepatoprotective, and anticancer activities across in vitro and in vivo models (PMID 37359709). Erukainure et al. (2021) in Current Pharmaceutical Design established kolaviron as a biflavonoid with demonstrated efficacy in attenuating oxidative stress, modulating inflammatory cytokines, and protecting hepatic and renal tissues in preclinical studies (PMID 33185157). Ilechie et al. (2020) published a clinical study in Acta Ophthalmologica showing that oral consumption of Garcinia kola significantly lowered intraocular pressure in human participants, supporting its traditional use for glaucoma management (PMID 32275352). Ahidjo et al. (2024) in Brain Communications demonstrated that Garcinia kola extract exhibited therapeutic potential against experimental toxoplasmosis in rats, reducing parasitic burden and neuroinflammation (PMID 39130514).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Alkaloids (Caffeine, Theobromine): Stimulate mental alertness, stamina, and cognitive vitality. - Flavonoids and Polyphenols (Kolaviron): Potent antioxidants that combat oxidative stress and reduce inflammation. - Tannins and Saponins: Offer antimicrobial activity and support immune and digestive health. - Vitamins (A, C, E): Support immune resilience, skin health, and cellular regeneration. - Minerals (Potassium, Calcium, Magnesium, Phosphorus): Promote nerve, muscle, and bone integrity. - Phytosterols and Coumarins: Contribute to metabolic regulation and systemic anti-inflammatory effects.
Reported Mechanism (Provisional)
Kolaviron, the principal biflavonoid complex of Garcinia kola, scavenges reactive oxygen species (ROS) and reactive nitrogen species (RNS) by donating hydrogen atoms from its hydroxyl groups, while simultaneously upregulating endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) via Nrf2/ARE pathway activation (PMID 33185157). Its anti-inflammatory mechanism involves suppression of NF-κB nuclear translocation and consequent downregulation of pro-inflammatory mediators including TNF-α, IL-6, IL-1β, and COX-2, while terpenoids such as garcinia acid and garcinoic acid inhibit lipoxygenase (LOX) activity (PMID 37359709). The antimicrobial alkaloids intercalate with microbial DNA to inhibit replication and transcription, while xanthone derivatives disrupt bacterial membrane integrity through phospholipid bilayer perturbation; additionally, polyphenolic fractions modulate hepatic phase I (CYP1A, CYP2B) and phase II (glutathione-S-transferase, UDP-glucuronosyltransferase) detoxification enzymes, mediating the compound's hepatoprotective effects (PMID 35528115; PMID 34904497). The intraocular pressure-lowering effect is attributed to enhanced aqueous humor outflow facilitated by smooth muscle relaxation via nitric oxide-mediated vasodilation and prostaglandin pathway modulation (PMID 32275352).
Clinical Narrative (Provisional)
Current evidence consists primarily of in vitro studies and animal models rather than robust human clinical trials. Rat studies using 200 mg/kg doses demonstrated cardioprotective effects by increasing Akt/protein kinase B expression and reducing oxidative stress markers including malondialdehyde levels. Aqueous leaf extracts showed strongest ferric reducing antioxidant capacity at 5-7 mg/mL concentrations (p<0.05) in laboratory studies. Human clinical trials are ongoing but published data remains limited for establishing definitive therapeutic dosing and efficacy parameters.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.